Overview
Mingjun Rui practices in Sar, China. Rui is rated as an Experienced expert by MediFind in the treatment of EGFR Positive Lung Cancer. Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Adult Immune Thrombocytopenia, and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of EGFR Positive Lung Cancer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult Immune Thrombocytopenia
- Colorectal CancerRui isExperienced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerRui isExperienced. Learn about EGFR Positive Lung Cancer.
- Immune Thrombocytopenic Purpura (ITP)
- Lung CancerRui isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)